The association between hydroxychloroquine treatment and cardiovascular morbidity among rheumatoid arthritis patients

This publication has 30 references indexed in Scilit:

• 2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
  Arthritis Care & Research, 2012
• EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis
  Annals of the Rheumatic Diseases, 2010
• Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review
  Annals of the Rheumatic Diseases, 2010
• Disease activity as a risk factor for myocardial infarction in rheumatoid arthritis
  Annals of the Rheumatic Diseases, 2009
• American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease‐modifying antirheumatic drugs in rheumatoid arthritis
  Arthritis Care & Research, 2008
• Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part I
  Arthritis & Rheumatism, 2007
• Subclinical atherosclerosis in systemic lupus erythematosus (SLE): the relative contribution of classic risk factors and the lupus phenotype
  Rheumatology, 2007
• Rheumatoid factor and antibodies to cyclic citrullinated peptides are associated with severe extra-articular manifestations in rheumatoid arthritis
  Annals of the Rheumatic Diseases, 2007
• Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years
  Annals of the Rheumatic Diseases, 2003
• Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus
  Arthritis & Rheumatism, 1999